![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication September 5, 2006.
Revised December 4, 2006.
Accepted for publication December 5, 2006.
Etoposide, an important anticancer agent, undergoes
glucuronidation both in vitro and in vivo. In this study,
three isomeric glucuronides of etoposide, including one
phenolic (EPG) and two alcoholic glucuronides
(EAG1 and EAG2), were biosynthesized in vitro with human
liver microsomes (HLMs), and identified by
liquid chromatography-electrospray ionization-mass
spectrometry and confirmed by
-glucuronidase
cleavage. In vitro UDP-glucuronosyltransferase (UGT)
reaction screening with 12 recombinant human
UGTs demonstrated that etoposide glucuronidation is
mainly catalyzed by UGT1A1. Although UGT1A8
and 1A3 also catalyzed the glucuronidation of etoposide,
their activities were about 10 and 1% of
UGT1A1. Enzyme kinetic study indicated that the
predominant form of etoposide glucoronide in HLMs
and human intestinal microsomes (HIMs) was EPG, whereas
EAG1 and EAG2 were the minor
metabolites, with approximately 8-10% glucuronidation
rate of EPG. For the formation of EPG, the Vmax
of HLMs (110 pmol/min/mg protein) was very similar to
that of recombinant UGT1A1 (124
pmol/min/mg protein), whereas the Vmax of HIMs (54.4
pmol/min/mg protein) was 2-fold lower than those
of HIMs and UGT1A1. The Km values of HLMs (530 µM) and
HIMs (608 µM) were 2-fold higher than
that of UGT1A1 (285 µM). The Vmax/Km values for the
formation of EPG were 0.21 and 0.09 µl/min/mg
protein for HLMs and HIMs, respectively. The data
indicated that UGT1A1 is principally responsible for
the formation of etoposide glucuronides, mainly in the
form of phenolic glucuronide, suggesting that
etoposide can be used as a highly selective probe
substrate for human UGT1A1 in vitro.
Key words:
enzyme kinetics, glucuronidation, mass spectrometry, metabolite identification, UDP glucuronyltransferases